UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Strategy Inc
MSTR
|
+$1.21B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$855M |
| 3 |
Microsoft
MSFT
|
+$810M |
| 4 |
Advanced Micro Devices
AMD
|
+$805M |
| 5 |
Boeing
BA
|
+$739M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$561M |
| 2 |
Amneal Pharmaceuticals
AMRX
|
+$169M |
| 3 |
Eli Lilly
LLY
|
+$161M |
| 4 |
Unity
U
|
+$158M |
| 5 |
State Street SPDR S&P Regional Banking ETF
KRE
|
+$127M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.49% |
| 2 | Financials | 9.06% |
| 3 | Consumer Discretionary | 7.01% |
| 4 | Healthcare | 6.25% |
| 5 | Industrials | 6.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3826
Trustmark
TRMK
$2.75B
| $5.07M | ﹤0.01% |
143,404
+81,169
| +130% | +$2.93M |
|
|
DDL
3827
Dingdong
DDL
$503M
| $5.07M | ﹤0.01% |
1,546,161
+1,503,411
| +3,517% | +$5.82M |
|
3828
CALL
US Global Jets ETF
JETS
$800M
| $5.07M | ﹤0.01% |
+200,000
| New | +$4.73M |
|
3829
State Street SPDR Portfolio MSCI Global Stock Market ETF
SPGM
$1.78B
| $5.07M | ﹤0.01% |
80,055
-1,226
| -2% | -$79.5K |
|
3830
Digimarc Corp
DMRC
$178M
| $5.06M | ﹤0.01% |
135,184
+120,766
| +838% | +$3.94M |
|
3831
MiMedx Group
MDXG
$633M
| $5.06M | ﹤0.01% |
525,913
+246,145
| +88% | +$1.92M |
|
3832
JPMorgan US Tech Leaders ETF
JTEK
$4.44B
| $5.04M | ﹤0.01% |
66,639
-7,901
| -11% | -$586K |
|
3833
Invesco Biotechnology & Genome ETF
PBE
$292M
| $5.03M | ﹤0.01% |
75,676
-3,786
| -5% | -$261K |
|
3834
Progress Software
PRGS
$1.76B
| $5.03M | ﹤0.01% |
77,159
+50,455
| +189% | +$3.37M |
|
|
DPG
3835
Duff & Phelps Utility and Infrastructure Fund
DPG
$524M
| $5.02M | ﹤0.01% |
429,437
-33,440
| -7% | -$393K |
|
|
ORC
3836
Orchid Island Capital
ORC
$1.31B
| $5.02M | ﹤0.01% |
644,836
+453,032
| +236% | +$3.56M |
|
3837
Valmont Industries
VMI
$9.53B
| $5.01M | ﹤0.01% |
16,330
+6,796
| +71% | +$2.19M |
|
3838
Certara
CERT
$1.25B
| $5.01M | ﹤0.01% |
470,222
+383,991
| +445% | +$4.17M |
|
3839
PUT
TE Connectivity
TEL
$62.6B
| $5M | ﹤0.01% |
35,000
-40,100
| -53% | -$5.97M |
|
3840
BlackRock Science and Technology Trust
BST
$1.69B
| $5M | ﹤0.01% |
136,863
+1,747
| +1% | +$64.1K |
|
|
SCHR
3841
Schwab Intermediately-Term US Treasury ETF
SCHR
$13.3B
| $5M | ﹤0.01% |
205,695
+25,323
| +14% | +$623K |
|
|
CIM
3842
Chimera Investment
CIM
$1B
| $5M | ﹤0.01% |
356,836
-36,457
| -9% | -$547K |
|
|
ARI
3843
Apollo Commercial Real Estate
ARI
$885M
| $4.99M | ﹤0.01% |
576,745
+192,020
| +50% | +$1.73M |
|
3844
Reaves Utility Income Fund
UTG
$3.61B
| $4.99M | ﹤0.01% |
157,576
+651
| +0.4% | +$21.4K |
|
3845
PUT
CME Group
CME
$94.8B
| $4.99M | ﹤0.01% |
21,500
| – | – |
|
3846
Invesco CurrencyShares Japanese Yen Trust
FXY
$451M
| $4.98M | ﹤0.01% |
85,012
+7,098
| +9% | +$430K |
|
3847
Select Water Solutions
WTTR
$2.61B
| $4.98M | ﹤0.01% |
376,084
+187,976
| +100% | +$2.39M |
|
3848
Lifestance Health
LFST
$4.14B
| $4.98M | ﹤0.01% |
675,384
+584,816
| +646% | +$4.2M |
|
|
TWFG
3849
TWFG Inc
TWFG
$378M
| $4.97M | ﹤0.01% |
161,516
+160,832
| +23,513% | +$5M |
|
3850
PUT
Nice
NICE
$5.97B
| $4.96M | ﹤0.01% |
29,200
+15,000
| +106% | +$2.67M |
|
Similar funds
UBS Group's Q4 2024 Portfolio in Review
As of Q4 2024, UBS Group held 10,816 positions worth $541B, up 18% from $459B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
UBS Group deployed $80.6B of net new capital in Q4 2024, opening 1,382 new positions and adding to 6,044 existing holdings. Its largest new stake was Primo Brands: 1,234,826 shares worth $38M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was UnitedHealth, an estimated $561M trimmed.
- UBS Group's largest Q4 2024 buy was Primo Brands: 1,234,826 shares worth $38M.
- UBS Group added most to Strategy Inc in Q4 2024, an estimated $1.21B increase.
- UBS Group's biggest Q4 2024 reduction was UnitedHealth, cutting an estimated $561M.
- UBS Group fully exited CATALENT, INC. in Q4 2024, selling an estimated $86M.
- UBS Group's ten largest holdings make up 16% of its $541B portfolio in Q4 2024.
- UBS Group opened 1,382 new positions and closed 943 in Q4 2024.
- UBS Group's portfolio value rose 18% quarter-over-quarter to $541B.
Based on UBS Group's 13F filing for Q4 2024, filed 14 Feb 2025.